Catalyst Biosciences licenses seminal intellectual property in the field of protease therapeutics. From: BIOTECH Patent News | Date: August 1, 2005 | COPYRIGHT 2005 Biotech Patent News. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group.Copyright information

Catalyst Biosciences, Inc. (South San Francisco, CA) and Torrey Pines Institute for Molecular Studies (San Diego, CA) have entered into an exclusive worldwide license agreement for Catalyst's use of the Institute's seminal intellectual property covering protease engineering, selection and optimization. Catalyst is an emerging drug discovery and development company focused on advancing proteases as a new platform for biotherapeutics development in inflammation, cardiovascular diseas...